MANKIND PHARMA
Back to Cashflow Statement
|
MANKIND PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹5.27 Cr | ₹-740 Cr | ₹605 Cr | ₹-7.81 Cr | ₹-527 Cr |
What is the latest Cash Flow from Financing Activities ratio of MANKIND PHARMA ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹5.27 Cr |
Mar2023 | ₹-740 Cr |
Mar2022 | ₹605 Cr |
Mar2021 | ₹-7.81 Cr |
Mar2020 | ₹-527 Cr |
How is Cash Flow from Financing Activities of MANKIND PHARMA Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹5.27 Cr | Positive | |
Mar2023 | ₹-740 Cr | Negative | |
Mar2022 | ₹605 Cr | Positive | |
Mar2021 | ₹-7.81 Cr | Negative | |
Mar2020 | ₹-527 Cr | - |
Compare Cash Flow from Financing Activities of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹97,727.4 Cr | -0.4% | -7.8% | 9.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,420.0 Cr | -0.2% | -2.9% | 12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,572.0 Cr | 0.3% | 6.5% | 49% | Stock Analytics | |
CIPLA | ₹123,329.0 Cr | 1.1% | 1.8% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,396.0 Cr | -0.2% | 9.5% | 12.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,956.0 Cr | 1.9% | 0.4% | 14% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -0.4% |
-7.8% |
9.9% |
SENSEX | -0.8% |
-0.9% |
6.9% |
You may also like the below Video Courses